Literature DB >> 30218350

Overexpressed in colorectal carcinoma gene (OCC-1) upregulation and APPL2 gene downregulation in breast cancer specimens.

Abolfazl Ghalaei1, Maryam Kay1, Shiva Zarrinfam1, Parisa Hoseinpour2, Mehrdad Behmanesh1, Bahram M Soltani3.   

Abstract

Breast cancer is the most common cancer type and the second cause of cancer death in women. Different mechanisms are contributed to the initiation and progression of the breast cancer. OCC-1 and APPL2 neighboring genes located in 12q.23.3 human chromosome region are related to colorectal cancer. Here, we intended to investigate OCC-1 newly reported transcript variants and APPL2 gene expression alteration in breast cancer specimens and investigate OCC-1 variants overexpression effect on APPL2 and on cell cycle status. Rt-qPCR analysis indicated that the expression level of OCC-1A/B and OCC-1D (not OCC-1C) transcript variants has been increased while, APPL2 gene expression level has been decreased in breast cancer specimen, compared to their normal pairs. Therefore, a negative correlation of expression is evident between APPL2 and OCC-1 genes in breast cancer specimen. Unlike OCC-1A/B which encodes a small protein, OCC-1D noncoding RNA overexpression lead to APPL2 downregulation in MCF7 cells. Consistently, OCC-1D overexpression resulted in increased sub-G1 cell population in MCF7 cells, detected by flow cytometry. Altogether, these results suggest that OCC1-D variant have an inhibitory effect on APPL2 expression and may regulate the cell cycle status.

Entities:  

Keywords:  APPL2; Breast cancer; OCC-1 gene

Mesh:

Substances:

Year:  2018        PMID: 30218350     DOI: 10.1007/s11033-018-4336-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  16 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  The characteristic landscape of lncRNAs classified by RBP-lncRNA interactions across 10 cancers.

Authors:  Qiang Zhang; Yunzhen Wei; Zichuang Yan; Cheng Wu; Zhiqiang Chang; Yinling Zhu; Kun Li; Yan Xu
Journal:  Mol Biosyst       Date:  2017-04-26

Review 4.  Cis-acting noncoding RNAs: friends and foes.

Authors:  Sònia Guil; Manel Esteller
Journal:  Nat Struct Mol Biol       Date:  2012-11       Impact factor: 15.369

5.  A human cell line from a pleural effusion derived from a breast carcinoma.

Authors:  H D Soule; J Vazguez; A Long; S Albert; M Brennan
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

6.  Cloning of the mRNA of overexpression in colon carcinoma-1: a sequence overexpressed in a subset of colon carcinomas.

Authors:  Laurence Pibouin; Jacqueline Villaudy; Didier Ferbus; Martine Muleris; Marie-Thérèse Prospéri; Yurgos Remvikos; Gérard Goubin
Journal:  Cancer Genet Cytogenet       Date:  2002-02

7.  Rab31 and APPL2 enhance FcγR-mediated phagocytosis through PI3K/Akt signaling in macrophages.

Authors:  Jeremy C Yeo; Adam A Wall; Lin Luo; Jennifer L Stow
Journal:  Mol Biol Cell       Date:  2015-01-07       Impact factor: 4.138

8.  Alternative splicing of the OCC-1 gene generates three splice variants and a novel exonic microRNA, which regulate the Wnt signaling pathway.

Authors:  Hadi Najafi; Bahram M Soltani; Sadat Dokanehiifard; Shirzad Nasiri; Seyed Javad Mowla
Journal:  RNA       Date:  2016-10-21       Impact factor: 4.942

9.  Multifunctional protein APPL2 contributes to survival of human glioma cells.

Authors:  Beata Pyrzynska; Magdalena Banach-Orlowska; Marta Teperek-Tkacz; Katarzyna Miekus; Grazyna Drabik; Marcin Majka; Marta Miaczynska
Journal:  Mol Oncol       Date:  2012-09-05       Impact factor: 6.603

10.  A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen.

Authors:  Kang Wang; Jie Li; Yong-Fu Xiong; Zhen Zeng; Xiang Zhang; Hong-Yuan Li
Journal:  Sci Rep       Date:  2018-02-16       Impact factor: 4.379

View more
  2 in total

Review 1.  Genetic and molecular biology of breast cancer among Iranian patients.

Authors:  Meysam Moghbeli
Journal:  J Transl Med       Date:  2019-07-08       Impact factor: 5.531

2.  Pan-cancer analysis of the prognostic value of C12orf75 based on data mining.

Authors:  Guangzhen Cai; Guannan Jin; Junnan Liang; Ganxun Li; Xiaoping Chen; Huifang Liang; Zeyang Ding
Journal:  Aging (Albany NY)       Date:  2021-06-01       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.